Agenus maintains a worldwide footprint by collaborations and partnerships with primary pharmaceutical and biotechnology businesses in North America, Europe and Asia. Its agreements incorporate analysis and enhancement collaborations, license arrangements and co-enhancement systems aimed toward accelerating the interpretation of novel immunotherapie